Nestlé Health Science (China) Co., Ltd., Nestlé's medical nutrition company, provides a series of full nutrition formulas, which are personalized and complete nutrition solutions customized for the rehabilitated population and the elderly, which can be used as a single source of nutrition or as a daily nutritional supplement
Jiashan seriesComplete Nutrition Formula Powder, a personalized total nutrition program customized for rehabilitated people and the elderly. Scientifically formulated to provide balanced and comprehensive nutrition. It can be used as a single source of nutrition or as a daily nutritional supplement.
A small mealIt is a scientific feeding program customized for picky eaters, picky eaters, and children with poor growth and development. A complete nutritional formula designed according to the nutrients required by the dietary pyramid of toddlers and children. It can be used as a single source of nutrients to provide comprehensive and balanced nutrition; It can also be used as a daily nutritional supplement to promote children's growth and development, and help catch up with growth. “Use under the guidance of a doctor or dietitian”。
Founded in 2011, Nestlé Health Sciences is a next-generation health sciences company. We are committed to developing nutritional therapies to drive change in health management and serve consumers, patients, and partners across the healthcare spectrum.
By investing in innovative industries and leveraging cutting-edge science, we strive to create a new industry between food and medicine that builds on the existing safe nutritional therapies, with comparable quality of life, clinical value and health economic value.
Nestlé Health Science is a global company headquartered in Vevey, Switzerland, with around 3,000 employees worldwide. Initially, the company was founded on the basis of the Nestlé Group's health and nutrition business. Today, we are able to meet the personalized nutritional needs of nearly 2.5 million people every day and serve hundreds of millions of people each year through our self-paid portfolio of health supplements and medical nutrition (often prescription drugs) brands.
To achieve transformational breakthroughs, we are actively identifying and commercializing advances in basic science, including understanding the impact of nutrients on disease at the cellular level and their greater potential therapeutic effects. Currently, we have a number of acquisitions and investments, including: Vitaflo, a UK-based company that offers a portfolio of clinical nutrition solutions for metabolic disorders, particularly for inborn errors of metabolism (i.e., IEM); Prometheus Laboratories, Inc., a diagnostic and pharmaceutical company for gastrointestinal diseases (i.e., GI) and oncology; Pamlab, Inc., which provides prescription medical foods for patients with brain health and metabolic disorders; Nutrition Science Partners, Inc. (joint venture), which explores the potential of plant nutrition, with a focus on gastrointestinal diseases; and Accera (minority stake), which supports trials of nutritional therapies for patients with Alzheimer's disease.
We have access to the same research being conducted by the Nestlé Institute of Health Sciences, and with the help of Nestlé's taste and nutrition experts, we are confident that we can achieve our ambitions with innovative nutritional therapies.
